Aztreonam for inhalation solution

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Cystic fibrosis, chronic pulmonary pseudomonas aeruginosa infections

Manufacturer:

Gilead Sciences Canada Inc.

Call for patient/clinician input open:

November 26, 2010

Brand Name:

Cayston

Project Line:

Reimbursement Review

Project Number:

SR0220-000

Call for patient/clinician input closed:

January 31, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Cystic fibrosis (CF) with chronic pulmonary pseudomonas aeruginosa infections

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

July 18, 2011

Last Updated : December 2, 2010